The key for me in that article was Horizon's use of a fine-tuned sales staff to get their scammy drug sold. KTOV will need a partner for KIT-302 if they want similar results.
Designated and targeted market is big for Consensi. It needs the right partner in US/EU. Don’t forget they have their own business team and they engaged external consultants in order to find US/EU Partners (per the presentation partnership talks are on-going since March).